Coagulation factor viia Intravenous and Ipol

• Generic Name: coagulation factor viia
• Dosage Forms: n.a.
• Other Brand Names:

  NovoSeven RT with MixPro, Novoseven, NovoSeven RT

Factor VIIa is used to treat and prevent bleeding episodes in patients with Hemophilia A or B who have formed antibodies against other clotting proteins (eg, Factor VIII or Factor IX) that help bleeding to stop. It is also used to treat or prevent bleeding in patients with acquired hemophilia, congenital Factor VII deficiency, or Glanzmann's thrombasthenia (a bleeding disorder that is caused by a blood abnormality) that has been treated with platelet transfusions but did not work well.

Factor VIIa is a man-made protein produced to replicate the naturally occurring activated factor VII (factor VIIa) in the body. It is used to stop bleeding of injuries for patients with hemophilia by helping the blood to clot.

Factor VIIa is to be given only by or under the direct supervision of your doctor.

• Generic Name: poliovirus vaccine, inactivated
• Dosage Forms: injection
• Other Brand Names: Ipol

Polio affects the central nervous system and spinal cord. It can cause muscle weakness and paralysis. Polio is a life threatening condition because it can paralyze the muscles that help you breathe.

The polio vaccine is used to help prevent these diseases in children and adults.

This vaccine works by exposing you to a small dose of the virus, which causes the body to develop immunity to the disease. This vaccine will not treat an active infection that has already developed in the body.

Polio vaccine is for use in adults and children who are at least 6 weeks old.

Like any vaccine, the polio vaccine may not provide protection from disease in every person.